A phase 2 trial finds that for patients with HER2+ metastatic colorectal cancer, dual HER2-inhibitor therapy can be a similarly efficacious but less toxic alternative to EGFR inhibitor therapy.

A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research and the like.

Meetings designed to distribute grant money to fund research were canceled as part of a communications freeze at health ...

I’m a health researcher. NIH’s pause on research grants could have a devastating cost. This is a potentially devastating ...

Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...

Chrystal Starbird, a cancer researcher at the University of North Carolina School of Medicine, had been preparing to serve on ...

Cancellations of NIH grant review panels, in particular, could affect cancer research grants and funding. In these NIH grant ...

A flurry of scientific gatherings and panels across federal science agencies were canceled on Wednesday, at a time of ...

An email obtained by NPR says NIH employees are subject to a travel freeze and offers of employment are being rescinded.

A temporary freeze on meetings on the National Institutes of Health could lead to delays in disbursing research grants and in ...

The human body breaks alcohol down into chemicals that can damage DNA, causing cells to grow out of control and become cancerous, according to the National Cancer Institute. Additionally ...

Survival rates can give you an idea of what percentage of people with the same type and stage of cancer are still alive a certain amount of time (usually 5 years) after they were diagnosed. They can’t ...